Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jun 1995

Hughes J H, Cohen M B, Robinson R A

Abstract excerpt

p53 is a tumor suppressor protein that is overexpressed in a variety of human neoplasms, including prostatic adenocarcinoma. Recent studies have demonstrated a significant positive correlation between extent of p53 overexpression and tumor grade in prostatic adenocarcinoma. Because it appears that mutations of p53 might play a role in the pathogenesis of a subset of biologically aggressive prostatic neoplasms, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Immunohistochemistry

Share to Mutation

Share to Prostatic Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 7675761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

p53 immunoreactivity in primary and metastatic prostatic adenocarcinoma.PMID 7675761Read ↗

Immunohistochemical determination of p53 protein in prostatic cancer and prostatic intraepithelial neoplasms.Semantic proximity Read ↗

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.Semantic proximity Read ↗

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.Semantic proximity Read ↗

Tumor suppressor gene p53 mutations in human prostate cancer.Semantic proximity Read ↗

Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation.Semantic proximity Read ↗

An uncertain role for p53 gene alterations in human prostate cancers.Semantic proximity Read ↗

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.Semantic proximity Read ↗

p53 mutations in matched primary and metastatic human tumors.Semantic proximity Read ↗

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.Semantic proximity Read ↗

p53 oncogene mutations in human prostate cancer specimens.Semantic proximity Read ↗

p53 gene alterations in human prostate carcinoma.Semantic proximity Read ↗

Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.